TNF and Thrombocytopenia: Recently, Wan B et al. reported that rhIL-11 could promote the recovery of PCs, reduce the expression of TNF-alpha and IL-6, alleviate inflammatory response, thus reducing the mortality of patients with thrombocytopenia [35].